These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14949094)

  • 21. Darinaparsin: a novel organic arsenical with promising anticancer activity.
    Mann KK; Wallner B; Lossos IS; Miller WH
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine disruptive effects of inorganic arsenicals.
    Sakurai T; Himeno S
    Environ Sci; 2006; 13(2):101-6. PubMed ID: 16788561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
    Cunningham ML; Zvelebil MJ; Fairlamb AH
    Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.
    Fairlamb AH; Smith K; Hunter KJ
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):223-31. PubMed ID: 1501642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivalency in the inhibition of oxidative protein folding by arsenic(III) species.
    Sapra A; Ramadan D; Thorpe C
    Biochemistry; 2015 Jan; 54(2):612-21. PubMed ID: 25506675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
    Carter NS; Fairlamb AH
    Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The trypanocidal activity of some pyrimidylaminophenylarsonic compounds.
    AINLEY AD; DAVEY DG
    Br J Pharmacol Chemother; 1958 Sep; 13(3):244-9. PubMed ID: 13584724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic phenyl arsonic acid compounds with potent antileukemic activity.
    Liu XP; Narla RK; Uckun FM
    Bioorg Med Chem Lett; 2003 Feb; 13(3):581-3. PubMed ID: 12565976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomolecules bearing the S- or SeAsMe2 function: amino acid and steroid derivatives.
    Banks CH; Daniel JR; Zingaro RA
    J Med Chem; 1979 May; 22(5):572-5. PubMed ID: 458808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells.
    Woo SH; Park MJ; An S; Lee HC; Jin HO; Lee SJ; Gwak HS; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 May; 95(1):120-30. PubMed ID: 15723287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].
    Tajima M
    Nihon Yakurigaku Zasshi; 2005 Jun; 125(6):389-96. PubMed ID: 16079563
    [No Abstract]   [Full Text] [Related]  

  • 34. Action of arsenicals on infection of mice with greylung virus.
    ANDREWES CH; NIVEN JS
    J Pathol Bacteriol; 1953 Oct; 66(2):565-7. PubMed ID: 13118465
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
    Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R
    Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals.
    Fan XY; Chen XY; Liu YJ; Zhong HM; Jiang FL; Liu Y
    Sci Rep; 2016 Jul; 6():29865. PubMed ID: 27432798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
    Mudipalli A; Owen RD; Preston RJ
    Int J Oncol; 2005 Sep; 27(3):769-78. PubMed ID: 16077927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of vicinal dithiol-containing proteins by arsenical-based affinity chromatography.
    Kalef E; Gitler C
    Methods Enzymol; 1994; 233():395-403. PubMed ID: 8015475
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
    Diaz Z; Mann KK; Marcoux S; Kourelis M; Colombo M; Komarnitsky PB; Miller WH
    Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human sperm immobilizing activity of aminophenyl arsenic acid and its N-substituted quinazoline, pyrimidine, and purine derivatives: protective effect of glutathione.
    Uckun FM; Liu XP; D'Cruz OJ
    Reprod Toxicol; 2002; 16(1):57-64. PubMed ID: 11934532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.